Why the study?
There is wide variation in the proportion of patients with non-ST-segment-elevation ACS undergoing an invasive strategy who receive revascularization despite early angiography.
Cohort (n=50,302)
Yes
Hazard Ratio: 0.64 (95% CI 0.6–0.69)
Revascularization linked to lower mortality in NSTE-ACS; leaves open whether selection bias drives benefit or if targeted use improves outcomes.
BACKGROUND: Although an invasive strategy is a class I clinical practice guideline for non-ST-segment-elevation acute coronary syndromes, there is wide variation in the proportion of patients who undergo revascularization despite early angiography. We sought to identify the predictors of early revascularization versus medical therapy alone in patients with non-ST-segment-elevation acute coronary syndrome undergoing an invasive strategy and to assess their clinical outcomes. METHODS AND RESULTS: We assessed revascularization status by percutaneous coronary intervention or coronary artery bypass grafting within 7 days of the index angiogram in all patients with non-ST-segment-elevation acute coronary syndrome who underwent an invasive strategy in Ontario, Canada, from October 1, 2008, to October 31, 2013, with follow-up through December 31, 2014. The primary outcome was mortality. Multivariable hierarchical logistic models identified predictors of revascularization, and multivariable Cox models with treatment strategy as a 3-level time-varying covariate assessed the relationship between revascularization status and clinical outcomes. We identified 50 302 patients of whom 34 288 (68.2%) underwent revascularization (percutaneous coronary intervention: 28 011 and coronary artery bypass grafting: 6277). There was a 2-fold variation in revascularization rates across hospitals. A higher risk presentation significantly predicted revascularization (odds ratio, 1.26; 95% confidence interval, 1.18-1.35), as did having the angiogram by an interventional cardiologist (odds ratio, 1.76; 95% confidence interval, 1.57-1.98). Revascularized patients with either percutaneous coronary intervention (hazard ratio, 0.64; 95% confidence interval, 0.60-0.69) or coronary artery bypass grafting (hazard ratio, 0.53; 95% confidence interval, 0.47-0.60) had improved survival compared with medically treated patients. CONCLUSIONS: Although the majority of patients with non-ST-segment-elevation acute coronary syndrome who underwent an early invasive approach received revascularization, there was wide variation. Revascularization was associated with significantly improved survival.
No takes yet. Share an insight, caveat, or question.
Wijeysundera et al. (2016) conducted a cohort in Non-ST-segment-elevation acute coronary syndrome (n=50,302). Revascularization (percutaneous coronary intervention or coronary artery bypass grafting) vs. Medical therapy alone was evaluated on Mortality (HR 0.64, 95% CI 0.60-0.69). Revascularization with PCI (HR 0.64; 95% CI 0.60-0.69) or CABG (HR 0.53; 95% CI 0.47-0.60) was associated with significantly improved survival compared with medical therapy alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: